FOOT AND ANKLE BIOMECHANICS WITH ORTHOSIS AMBULATION
借助矫形器行走的足部和踝部生物力学
基本信息
- 批准号:2751276
- 负责人:
- 金额:$ 13.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-03-01 至 2002-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): This project deals
with the issue of restoring lower limb function in patients with severe
arthritis of the ankle or hindfoot who require the use of a standard
ankle foot orthosis (AFO) or hindfoot orthosis (articulated, non-
articulated) and to lock the ankle or hindfoot for stability during
gait. These patients have stiff, arthritic joints which are painful and
impair their ability to walk. Currently, these types of patients are
fitted with a conventional rigid polypropylene AFO to limit movement.
These devices restrict ankle, hindfoot, and midfoot movement during
walking. This may produce inefficient gait, unnecessarily immobilize
unaffected joints, and may not be tolerated by debilitated patients
because of their weight or bilateral impairments. The goal of this
project is to test two lightweight hindfoot orthoses (articulated and
non-articulated) and a standard AFO in normal and arthritic subjects in
three different walking environments.
In level, side-slope, and ramp walking, they propose to: 1) perform
objective measurements of gait patterns for the three orthoses in normal
subjects; and 2) test the performance of these three orthoses in
patients with ankle or subtalar arthritis. The results of these studies
are expected to improve the efficacy of gait in patients with arthritis
who require conventional AFO treatment. In addition to patients with
arthritis, these orthoses will be useful for patients with ankle
instability, subtalar instability, and neuromuscular disorders.
描述(改编自申请者摘要):本项目涉及
重症高血压患者的肢体功能恢复问题
脚踝或后足关节炎需要使用标准
踝足矫形器(AFO)或后足矫形器(关节,非
关节),并锁定脚踝或后脚以保持稳定
步态。这些患者关节僵硬,关节炎,疼痛和
会削弱他们的行走能力。目前,这些类型的患者是
配有传统的刚性聚丙烯AFO,以限制移动。
这些装置限制脚踝、后足和中足的运动。
走路。这可能会产生低效的步态,不必要的静止
未受影响的关节,虚弱的患者可能无法忍受
因为他们的体重或双侧损伤。这样做的目的是
项目是测试两个轻型后脚矫形器(关节和
和一个标准的AFO在正常和关节炎受试者中
三种不同的行走环境。
在水平、斜坡和坡道行走中,他们建议:1)执行
正常人三种矫形器步态的客观测量
受试者;以及2)测试这三种矫形器在
有脚踝或距下关节炎的患者。这些研究的结果
有望改善关节炎患者的步态疗效
他们需要传统的AFO治疗。除了患有癌症的患者
关节炎,这些矫形器将对脚踝患者有用
不稳定、距下不稳定和神经肌肉疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HAROLD B KITAOKA其他文献
HAROLD B KITAOKA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HAROLD B KITAOKA', 18)}}的其他基金
FOOT AND ANKLE BIOMECHANICS WITH ORTHOSIS AMBULATION
借助矫形器行走的足部和踝部生物力学
- 批准号:
6362471 - 财政年份:1999
- 资助金额:
$ 13.07万 - 项目类别:
FOOT AND ANKLE BIOMECHANICS WITH ORTHOSIS AMBULATION
借助矫形器行走的足部和踝部生物力学
- 批准号:
6164026 - 财政年份:1999
- 资助金额:
$ 13.07万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Tissue tropism of PD-1 therapy in ulcerative colitis and rheumatoid arthritis
PD-1治疗溃疡性结肠炎和类风湿性关节炎的组织向性
- 批准号:
MR/Y009681/1 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Fellowship
Do autoantibodies to aberrantly glycosylated MUC1 drive extra-articular rheumatoid arthritis, and can GSK assets prevent driver antigen formation?
针对异常糖基化 MUC1 的自身抗体是否会导致关节外类风湿性关节炎,GSK 资产能否阻止驱动抗原形成?
- 批准号:
MR/Y022947/1 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Research Grant
Preclinical development of an extracellular vesicle biotherapeutic for juvenile idiopathic arthritis
幼年特发性关节炎细胞外囊泡生物治疗药物的临床前开发
- 批准号:
10068495 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Collaborative R&D
The delivery of miR-9 and RasGRP4 siRNA via high selectivity bispecific antibody conjugated lactosome: Targeting therapy for rheumatoid arthritis (RA) active synovial macrophage and osteoclast
通过高选择性双特异性抗体缀合乳糖体递送 miR-9 和 RasGRP4 siRNA:类风湿性关节炎 (RA) 活性滑膜巨噬细胞和破骨细胞的靶向治疗
- 批准号:
24K19237 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Exploring the inflammatory mediators degraded by MMP-2 in MMP-2-deficient mice with knee arthritis through a novel TMT-TAILS quantitative proteomics
通过新型 TMT-TAILS 定量蛋白质组学探索 MMP-2 缺陷型膝关节炎小鼠中 MMP-2 降解的炎症介质
- 批准号:
24K19850 - 财政年份:2024
- 资助金额:
$ 13.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of an adaptive platform trial to prevent Rheumatoid Arthritis in partnership with First Nations People.
与原住民合作开发预防类风湿关节炎的适应性平台试验。
- 批准号:
491810 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Operating Grants
The role of diet, as mediated by the gut microbiome, on childhood arthritis disease activity: a feasibility intervention study.
肠道微生物组介导的饮食对儿童关节炎疾病活动的作用:一项可行性干预研究。
- 批准号:
489316 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Operating Grants
DEMORA: DEep spatial characterization of synovial MacrOphages in Rheumatoid Arthritis
DEMORA:类风湿性关节炎滑膜巨噬细胞的深度空间特征
- 批准号:
EP/Y027760/1 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Fellowship
Investigation of hypoxia-inducible factor-1 (HIF-1) as a novel therapeutic target for juvenile idiopathic arthritis.
研究缺氧诱导因子-1 (HIF-1) 作为幼年特发性关节炎的新治疗靶点。
- 批准号:
23K14987 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel first-in-class Therapeutics for Rheumatoid Arthritis
类风湿关节炎的一流新疗法
- 批准号:
10696749 - 财政年份:2023
- 资助金额:
$ 13.07万 - 项目类别:














{{item.name}}会员




